RUSSO, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 160
EU - Europa 93
AS - Asia 69
AF - Africa 11
Totale 333
Nazione #
US - Stati Uniti d'America 160
IT - Italia 60
SG - Singapore 47
NL - Olanda 15
CN - Cina 14
CI - Costa d'Avorio 11
IN - India 8
DE - Germania 5
UA - Ucraina 5
FI - Finlandia 4
IE - Irlanda 2
ES - Italia 1
GB - Regno Unito 1
Totale 333
Città #
Singapore 42
Chandler 25
Ashburn 15
Amsterdam 14
Naples 14
Santa Clara 14
Napoli 7
Pune 7
Boston 4
Des Moines 4
Jacksonville 4
Millbury 4
Pomigliano D'arco 4
Princeton 4
Helsinki 3
Acquaviva Delle Fonti 2
Dublin 2
Gualtieri 2
Hebei 2
Lawrence 2
Nanjing 2
Nocera Inferiore 2
Sorrento 2
Tianjin 2
Vittorio Veneto 2
Agropoli 1
Bari 1
Beijing 1
Caivano 1
Cologne 1
Dallas 1
Frankfurt am Main 1
Jiaxing 1
Kronberg 1
Los Angeles 1
Madrid 1
Marano 1
Nanchang 1
Orange 1
Palermo 1
Pozzuoli 1
San Giovanni Lupatoto 1
San Giuseppe Vesuviano 1
Sedriano 1
Shenyang 1
The Dalles 1
Washington 1
Wilmington 1
Totale 208
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 65
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 44
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 38
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 36
Quattro nuove stazioni della linea 1 della Metropolitana di Napoli: problematiche geotecniche, procedure di analisi e scelte progettuali 35
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 27
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 21
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 21
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 20
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 18
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 10
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 7
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 7
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 6
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 4
Totale 359
Categoria #
all - tutte 2.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 2 0 0 0 1 1 1 1
2020/202118 0 1 0 3 5 0 1 0 7 0 1 0
2021/202231 0 0 0 0 0 0 0 0 0 6 12 13
2022/202390 6 2 0 3 13 8 2 12 19 19 6 0
2023/202491 1 14 18 6 4 13 0 13 2 5 12 3
2024/202583 23 15 1 13 31 0 0 0 0 0 0 0
Totale 359